MedTrace Logo

Feasibility Trial of ValenTx Endo Bypass System

NCT01207804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-03-17

No results posted yet for this study

Summary

The purpose of the study is to provide initial clinical data to support the feasibility of use of the ValenTx Endo Bypass system in enhancing weight loss and co-morbidity resolution in morbidly obese patients.

Conditions

Interventions

DEVICE

ValenTx Endo Bypass System

Patient is implanted with device and followed for 12 weeks

Sponsors & Collaborators

  • ValenTx, Inc.

    lead INDUSTRY

Principal Investigators

  • Roberto Rumbaut, MD · Hospital San Jose Tec

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2009-03-31
Completion
2009-05-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01207804 on ClinicalTrials.gov